The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 500
- Registration Number
- NCT01634984
- Locations
- 🇨🇳
Jin Zhang, Tianjin, China
External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)
Phase 2
- Conditions
- Postoperative FistulaComplications of Surgical and Medical Care: General Terms
- Interventions
- Procedure: Internal Drainage of Pancreatic Duct after pancreatomy
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2016-02-17
- Target Recruit Count
- 120
- Registration Number
- NCT01634971
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer
Phase 2
Completed
- Conditions
- Non-small Cell Lung CancerSquamous Cell Carcinoma
- Interventions
- First Posted Date
- 2012-06-29
- Last Posted Date
- 2019-11-05
- Target Recruit Count
- 96
- Registration Number
- NCT01631357
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 100
- Registration Number
- NCT01618474
- Locations
- 🇨🇳
Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
Phase 2
Withdrawn
- Conditions
- Pancreatic Cancer
- Interventions
- Drug: Gemcitabine, placebo
- Locations
- 🇨🇳
TianjinCIH, Tianjin, Tianjin, China
Trial of Endostar Combined With CHOPT for T Cell Lymphoma
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2015-11-04
- Target Recruit Count
- 30
- Registration Number
- NCT01430013
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas
Not Applicable
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Procedure: Therapeutic Chemoembolization
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2017-06-12
- Target Recruit Count
- 2840
- Registration Number
- NCT01393093
- Locations
- 🇨🇳
Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients
Not Applicable
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: TP regimen
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2016-02-17
- Target Recruit Count
- 160
- Registration Number
- NCT01393080
- Locations
- 🇨🇳
Tianjian Medical University Cancer Institue and Hospital, Tianjin, Tianjin, China
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)
Not Applicable
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Other: Therapeutic Chemoembolization
- First Posted Date
- 2011-07-13
- Last Posted Date
- 2015-12-18
- Target Recruit Count
- 2480
- Registration Number
- NCT01393197
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
GWAS Research of Lung Cancer in Tianjin
- Conditions
- Primary CarcinomaNon-small Cell Lung Cancer
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 500
- Registration Number
- NCT01255059
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China